ASA Medical Solutions Ltd Filleted Accounts Cover |  |

| ASA Medical Solutions Ltd |
|  | Company No. 09198313 |  |
|  |  | Information for Filing with The Registrar |  |  |
|  |  | 31 March 2025 |  |  |

ASA Medical Solutions Ltd Directors Report Registrar |  |

The Directors present their report and the accounts for the year ended 31 March 2025.
Principal activities |  |  |  |  |
The principal activity of the company during the year under review was provide medical recruitment solutions.
Directors |  |  |  |  |
The Directors who served at any time during the year were as follows:
M.B. James |  |  |  |  |  |  |
S. Knowles | (Resigned 19 December 2024) |  |  |  |
The above report has been prepared in accordance with the provisions applicable to companies subject to the small companies regime as set out in Part 15 of the Companies Act 2006.
Signed on behalf of the board |  |  |  |
S. Knowles |  |  |  |  |  |
Director |  |  |  |  |  |
10 December 2025 |  |  |  |  |  |

ASA Medical Solutions Ltd Balance Sheet Registrar |  |

at | 31 March 2025 |  |  |  |  |  |  |
Company No. | 09198313 |  | Notes | 2025 |  |  |  | 2024
|  |  |  |  |  | £ |  |  |  | £
Fixed assets |  |  |  |  |  |  |
| Intangible assets |  | 4 | - |  |  |  | -
| Tangible assets |  | 5 | 35,331 |  |  |  | 44,721
|  |  |  |  |  | 35,331 |  |  |  | 44,721
Current assets |  |  |  |  |  |  |
| Stocks |  | 6 | 5,000 |  |  |  | 6,711
| Debtors |  | 7 | 76,276 |  |  |  | 268,981
| Cash at bank and in hand |  |  | - |  |  |  | 6,686
|  |  |  |  |  | 81,276 |  |  |  | 282,378
Creditors: Amount falling due within one year | 8 | (129,280) |  |  |  | (285,813)
Net current liabilities |  |  | (48,004) |  |  |  | (3,435)
Total assets less current liabilities |  |  | (12,673) |  |  |  | 41,286
Creditors: Amounts falling due after more than one year | 9 | (14,194) |  |  |  | (23,333)
Net (liabilities)/assets |  |  | (26,867) |  |  |  | 17,953
Capital and reserves |  |  |  |  |  |  |
| Called up share capital |  |  | 500 |  |  |  | 500
| Profit and loss account |  | 10 | (27,367) |  |  |  | 17,453
Total equity |  |  | (26,867) |  |  |  | 17,953
These accounts have been prepared in accordance with the special provisions applicable to companies subject to the small companies regime of the Companies Act 2006.
For the year ended 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
As permitted by section 444 (5A)of the Companies Act 2006 the directors have not delivered to the Registrar a copy of the company's profit and loss account.
Approved by the board on 10 December 2025 and signed on its behalf by: |  |
S. Knowles |  |  |  |  |  |  |
Director |  |  |  |  |  |  |
10 December 2025 |  |  |  |  |  |  |  |

ASA Medical Solutions Ltd Notes to the Accounts Registrar |  |

for the year ended 31 March 2025 |  |  |  |  |  |  |  |

1 | General information |  |
| ASA Medical Solutions Ltd is a private company limited by shares and incorporated in England and Wales.
| Its registered number is: 09198313 |  |  |  |  |  |
| Its registered office is: |  |  |  |  |  |  |  |  |  |
| 24 |  |  |  |  |  |  |  |  |  |
| MK Business Centre |  |  |  |  |  |  |  |  |  |
| Foxhunter Drive |  |  |  |  |  |  |  |  |  |
| Milton Keynes |  |  |  |  |  |  |  |  |  |
| MK14 6GD |  |  |  |  |  |
| The accounts have been prepared in accordance with FRS 102 Section 1A - The Financial Reporting Standard applicable in the UK and Republic of Ireland and the Companies Act 2006.

2 | Accounting policies |  |  |  |  |  |  |  |

| Turnover |  |  |  |  |  |  |  |
| Turnover is measured at the fair value of the consideration received or receivable. Turnover is reduced for estimated customer returns, rebates and other similar allowances. Revenue from the sale of goods is recognised when all the following conditions are satisfied: • the Company has transferred to the buyer the significant risks and rewards of ownership of the goods; • the Company retains neither continuing managerial involvement to the degree usually associated with ownership nor effective control over the goods sold; • the amount of revenue can be measured reliably; • it is probable that the economic benefits associated with the transaction will flow to the Company; and • the costs incurred or to be incurred in respect of the transaction can be measured reliably. Specifically, revenue from the sale of goods is recognised when goods are delivered and legal title is passed.

| Intangible fixed assets |  |  |  |  |  |  |  |
| Intangible fixed assets are carried at cost less accumulated amortisation and impairment losses.

| Tangible fixed assets and depreciation |  |  |  |  |  |  |  |
| Tangible fixed assets held for the company's own use are stated at cost less accumulated depreciation and accumulated impairment losses. At each balance sheet date, the company reviews the carrying amount of its tangible fixed assets to determine whether there is any indication that any items have suffered an impairment loss. If any such indication exists, the recoverable amount of an asset is estimated in order to determine the extent of the impairment loss.
| Depreciation is provided at the following annual rates in order to write off the cost or valuation less the estimated residual value of each asset over its estimated useful life:
|  | Motor vehicles |  | 20% Reducing balance |  |  |  |  |  |
|  | Furniture, fittings and equipment |  | 33% Straight Line |  |  |  |  |  |

| Taxation |  |  |  |  |  |
| Income tax expense represents the sum of the tax currently payable and deferred tax. The tax currently payable is based on taxable profit for the year. Taxable profit differs from profit as reported in the profit and loss account because of items of income or expense that are taxable or deductible in other years and items that are never taxable or deductible. The Company's liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the end of the reporting period. Deferred tax is recognised on timing differences between the carrying amounts of assets and liabilities in the financial statements and the corresponding tax bases used in the computation of taxable profit. Deferred tax liabilities are generally recognised for all taxable temporary differences. Deferred tax assets are generally recognised for all deductible timing differences to the extent that it is probable that taxable profits will be available against which those deductible temporary differences can be utilised. The carrying amount of deferred tax assets is reviewed at the end of each reporting period and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered. Deferred tax assets and liabilities are measured at the tax rates that are expected to apply in the period in which the liability is settled or the asset realised, based on tax rates (and tax laws) that have been enacted or substantively enacted by the end of the reporting period. Current or deferred tax for the year is recognised in profit or loss, except when they relate to items that are recognised in other comprehensive income or directly in equity, in which case, the current and deferred tax is also recognised in other comprehensive income or directly in equity respectively.

| Trade and other debtors |  |  |  |  |  |  |  |
| Trade and other debtors are initially recognised at fair value and thereafter stated at amortised cost using the effective interest method, less impairment losses for bad and doubtful debts.

| Trade and other creditors |  |  |  |  |  |  |  |
| Short term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.

| Leased assets |  |  |  |  |  |  |  |
| Where the company enters into a lease which entails taking substantially all the risks and rewards of ownership of an asset, the lease is treated as a finance lease. Leases which do not transfer substantially all the risks and rewards of ownership to the Company are classified as operating leases. Assets held under finance leases are initially recognised as assets of the Company at their fair value at the inception of the lease or, if lower, at the present value of the minimum lease payments. The corresponding liability to the lessor is included in the balance sheet date as a finance lease obligation. Lease payments are apportioned between finance expenses and reduction of the lease obligation so as to achieve a constant rate of interest on the remaining balance of the liability. Finance expenses are recognised immediately in profit or loss, unless they are directly attributable to qualifying assets, in which case they are capitalised in accordance with the Company's policy on borrowing costs (see the accounting policy above). Assets held under finance leases are depreciated in the same way as owned assets. Operating lease payments are recognised as an expense on a straight-line basis over the lease term. In the event that lease incentives are received to enter into operating leases, such incentives are recognised as a liability. The aggregate benefit of incentives is recognised as a reduction of rental expense on a straight-line basis.

| Defined contribution pensions |  |  |  |  |  |  |  |
| The Company operates a defined contribution plan for its employees. A defined contribution plan is a pension plan under which the company pays fixed contributions into a separate entity. Once the contributions have been paid the company has no further payments obligations.
| The contributions are recognised as expenses when they fall due. Amounts not paid are shown in accruals in the balance sheet. The assets of the plan are held separately from the company in independently administered funds.

| Provisions |  |  |  |  |  |  |  |
| Provisions are made where an event has taken place that gives the Company a legal or constructive obligation that probably requires settlement by a transfer of economic benefit, and a reliable estimate can be made of the amount of the obligation. Provisions are charged as an expense to the profit and loss account in the year that the Company becomes aware of the obligation, and are measured at the best estimate at balance sheet date of the expenditure required to settle the obligation, taking into account relevant risks and uncertainties. When payments are eventually made, they are charged to the provision carried in the balance sheet.

3 | Employees |  |  |  |  |  |  |  |
|  |  |  |  |  |  |  |  |  | 2025 |  |  |  | 2024
|  |  |  |  |  |  |  |  |  | Number |  |  |  | Number
|  | The average monthly number of employees (including directors) during the year was: | 5 |  |  |  | 8

4 | Intangible fixed assets |  |  |  |  |  |  |  |
|  |  |  |  |  |  |  |  |  |  |  | Other |  | Total
|  |  |  |  |  |  |  |  |  |  |  | £ |  | £
|  | Cost |  |  |  |  |  |  |  |  |  |
|  | At 1 April 2024 |  |  |  |  |  |  |  | 10,000 |  | 10,000
|  | At 31 March 2025 |  |  |  |  |  |  |  | 10,000 |  | 10,000
|  | Amortisation and impairment |  |  |  |  |  |  |  |  |  |
|  | At 1 April 2024 |  |  |  |  |  |  |  | 10,000 |  | 10,000
|  | At 31 March 2025 |  |  |  |  |  |  |  | 10,000 |  | 10,000
|  | Net book values |  |  |  |  |  |  |  |  |  |
|  | At 31 March 2025 |  |  |  |  |  |  |  | - |  | -
|  | At 31 March 2024 |  |  |  |  |  |  |  | - |  | -

5 | Tangible fixed assets |  |  |  |  |  |  |  |  |  |
|  |  |  |  |  |  |  |  |  | Motor vehicles |  | Fixtures, fittings and equipment |  | Total
|  |  |  |  |  |  |  |  |  | £ |  | £ |  | £
|  | Cost or revaluation |  |  |  |  |  |  |  |  |  |
|  | At 1 April 2024 |  |  |  |  |  | 83,430 |  | 9,889 |  | 93,319
|  | At 31 March 2025 |  |  |  |  |  | 83,430 |  | 9,889 |  | 93,319
|  | Depreciation |  |  |  |  |  |  |  |  |  |
|  | At 1 April 2024 |  |  |  |  |  | 39,932 |  | 8,666 |  | 48,598
|  | Charge for the year |  |  |  |  |  | 8,699 |  | 691 |  | 9,390
|  | At 31 March 2025 |  |  |  |  |  | 48,631 |  | 9,357 |  | 57,988
|  | Net book values |  |  |  |  |  |  |  |  |  |
|  | At 31 March 2025 |  |  |  |  |  | 34,799 |  | 532 |  | 35,331
|  | At 31 March 2024 |  |  |  |  |  | 43,498 |  | 1,223 |  | 44,721

6 | Stocks |  |  |  |  |  |  |  |
|  |  |  |  |  |  |  |  |  | 2025 |  |  |  | 2024
|  |  |  |  |  |  |  |  |  | £ |  |  |  | £
|  | Work in progress |  |  |  | 5,000 |  |  |  | 6,711
|  |  |  |  |  |  |  |  |  | 5,000 |  |  |  | 6,711

7 | Debtors |  |  |  |  |  |  |  |
|  |  |  |  |  |  |  |  |  | 2025 |  |  |  | 2024
|  |  |  |  |  |  |  |  |  | £ |  |  |  | £
|  | Trade debtors |  |  |  | 76,276 |  |  |  | 266,375
|  | Other debtors |  |  |  | - |  |  |  | 1,064
|  | Prepayments and accrued income |  |  |  | - |  |  |  | 1,542
|  |  |  |  |  |  |  |  |  | 76,276 |  |  |  | 268,981

8 | Creditors: |  |  |  |  |  |  |  |
|  | amounts falling due within one year |  |  |  |  |  |  |  |
|  |  |  |  |  |  |  |  |  | 2025 |  |  |  | 2024
|  |  |  |  |  |  |  |  |  | £ |  |  |  | £
|  | Bank loans and overdrafts |  |  |  | 13,647 |  |  |  | -
|  | Other loans |  |  |  | 68,743 |  |  |  | 227,873
|  | Taxes and social security |  |  |  | 44,810 |  |  |  | 55,203
|  | Loans from directors |  |  |  | 1,939 |  |  |  | -
|  | Other creditors |  |  |  | 140 |  |  |  | 386
|  | Accruals and deferred income |  |  |  | 1 |  |  |  | 2,351
|  |  |  |  |  |  |  |  |  | 129,280 |  |  |  | 285,813

9 | Creditors: |  |  |  |  |  |  |  |
|  | amounts falling due after more than one year |  |  |  |  |  |  |
|  |  |  |  |  |  |  |  |  | 2025 |  |  |  | 2024
|  |  |  |  |  |  |  |  |  | £ |  |  |  | £
|  | Bank loans and overdrafts |  |  |  | 14,194 |  |  |  | 23,333
|  |  |  |  |  |  |  |  |  | 14,194 |  |  |  | 23,333

10 | Reserves |  |  |  |  |  |  |  |
|  | Profit and loss account - includes all current and prior period retained profits and losses.

11 | Dividends |  |  |  |  |  |  |  |
|  |  |  |  |  |  |  |  |  | 2025 |  |  |  | 2024
|  |  |  |  |  |  |  |  |  | £ |  |  |  | £
|  | Dividends for the period: |  |  |  |  |  |  |  |
|  | Dividends paid in the period |  |  |  | 36,954 |  |  |  | 96,336
|  |  |  |  |  |  |  |  |  | 36,954 |  |  |  | 96,336
|  | Dividends by type: |  |  |  |  |  |  |  |
|  | Equity dividends |  |  |  | 36,954 |  |  |  | 96,336
|  |  |  |  |  |  |  |  |  | 36,954 |  |  |  | 96,336

ASA Medical Solutions Ltd 09198313 31 March 2025 01 April 2024 false 10 December 2025 BTCSoftware AP Solution 2025 12.1.03 12.1.03 true 09198313 2024-04-01 2025-03-31 09198313 2025-03-31 09198313 2024-03-31 09198313 core:WithinOneYear 2025-03-31 09198313 core:WithinOneYear 2024-03-31 09198313 core:AfterOneYear 2025-03-31 09198313 core:AfterOneYear 2024-03-31 09198313 core:ShareCapital 2025-03-31 09198313 core:ShareCapital 2024-03-31 09198313 core:RetainedEarningsAccumulatedLosses 2025-03-31 09198313 core:RetainedEarningsAccumulatedLosses 2024-03-31 09198313 countries:UnitedKingdom 2024-04-01 2025-03-31 09198313 bus:RegisteredOffice 2024-04-01 2025-03-31 09198313 core:MotorVehicles 2024-04-01 2025-03-31 09198313 core:FurnitureFittingsToolsEquipment 2024-04-01 2025-03-31 09198313 2023-04-01 2024-03-31 09198313 core:OtherResidualIntangibleAssets 2024-04-01 09198313 2024-04-01 09198313 core:OtherResidualIntangibleAssets 2025-03-31 09198313 core:OtherResidualIntangibleAssets 2024-03-31 09198313 core:MotorVehicles 2024-04-01 09198313 core:FurnitureFittingsToolsEquipment 2024-04-01 09198313 core:MotorVehicles 2025-03-31 09198313 core:FurnitureFittingsToolsEquipment 2025-03-31 09198313 core:RetainedEarningsAccumulatedLosses 2024-04-01 2025-03-31 09198313 bus:AllOrdinaryShares 2024-04-01 2025-03-31 09198313 bus:SmallEntities 2024-04-01 2025-03-31 09198313 bus:FullAccounts 2024-04-01 2025-03-31 09198313 bus:AuditExempt-NoAccountantsReport 2024-04-01 2025-03-31 09198313 bus:Director2 2024-04-01 2025-03-31 09198313 bus:PrivateLimitedCompanyLtd 2024-04-01 2025-03-31 iso4217:GBP xbrli:pure